Taysha Gene Therapies, Inc. ($TSHA)
Filing Information
| Accession Number | 0001793412-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 14, 2026 |
| Document Date | Jan 12, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
590,000
Total Value
$0.00
P&L
+inf% (+$2,596,000.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF FINANCIAL OFFICER | Common Stock | โ | Jan 12, 2026 | Grant/Award | 359,000 | $0.00 | $0.00 | 1,546,603 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Employee Stock Option (right to buy) | Derivative | Jan 12, 2026 | Grant/Award | 231,000 | $0.00 | $0.00 | 231,000 | Direct | โ | View Details |